Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
certify, clearance, COSO, disagreement, discarded, DSMB, electrocardiogram, expert, explanatory, explore, grassi, Jericho, landscape, maximizing, mode, modification, promptly, psrt, regular, reinforce, residing, residual, secondary, slowdown, specialist, standing, suspected, vulnerable, York
Removed:
AB, acronym, activation, acute, adherence, AEs, aforementioned, AI, alcohol, altering, Artificial, bifurcation, big, biomarker, blocking, cardiovascular, cholesterol, chronically, clever, cohort, commonly, complicated, concept, constellation, consumption, corroborating, created, DCGL, DDI, decreasing, delta, die, disclosed, division, Dr, elevated, elicit, embedded, endothelial, enhanced, enrichment, eradicating, evading, eventually, evolved, Fordham, formation, Foster, genomic, globally, half, infect, infected, infection, Intelligence, Interaction, learning, machine, marked, measuring, metabolic, mg, microenvironment, mild, modelling, moderate, mortality, neutralizing, NW, optimize, pan, pathologic, persistent, persisting, PK, platelet, platform, preceded, premium, preventing, priori, problem, progressive, proof, reached, reap, recalculating, recurrence, regression, replication, representative, requirement, reviewing, Robert, SAD, sample, save, scarring, selectively, senior, showed, source, sugar, Suite, syndrome, systemic, target, temporal, ThinkEquity, tool, traded, transformation, underscore, underwritten, vaccination, vaccine, variable, verifying, viremia, widely
Filing tables
Filing exhibits
HEPA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-254996) and Form S-8 (Nos. 333-273269, 333-252188, 333-203867, 333-215662 and 333-234728) of Hepion Pharmaceuticals, Inc. (the Company) of our report dated April 10, 2023, except for Note 2, as to which the date is April 16, 2024, relating to the consolidated financial statements, which appears in this Annual Report on Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, P.C.
Woodbridge, New Jersey
April 16, 2024